Shortcomings in the Evaluation and Promotion of Hypnotic Drugs
- 16 October 1975
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 293 (16) , 826-827
- https://doi.org/10.1056/nejm197510162931611
Abstract
Insomnia is one of the most common symptoms treated by the physician, and pharmacologic agents are the most frequent method of treatment. Because of a number of shortcomings in the evaluation and promotion of hypnotic drugs, the physician is often provided insufficient and misleading information resulting in a general misuse of these drugs. These shortcomings fall into two general categories: general methodologic inadequacies of clinical hypnotic drug trials and incomplete labeling and misleading promotional claims for these drugs.Methodologic InadequaciesImportant methodologic problems in these trials include a failure to evaluate the effectiveness of hypnotic drugs with intermediate and long-term . . .Keywords
This publication has 4 references indexed in Scilit:
- Effectiveness of hypnotic drugs with prolonged use: Flurazepam and pentobarbitalClinical Pharmacology & Therapeutics, 1975
- Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependencePublished by American Medical Association (AMA) ,1974
- Hypnotic Drugs and Their EffectivenessArchives of General Psychiatry, 1970
- REM DeprivationArchives of General Psychiatry, 1968